CN102763759A - Black garlic chewing gum - Google Patents
Black garlic chewing gum Download PDFInfo
- Publication number
- CN102763759A CN102763759A CN2012102687226A CN201210268722A CN102763759A CN 102763759 A CN102763759 A CN 102763759A CN 2012102687226 A CN2012102687226 A CN 2012102687226A CN 201210268722 A CN201210268722 A CN 201210268722A CN 102763759 A CN102763759 A CN 102763759A
- Authority
- CN
- China
- Prior art keywords
- chewing gum
- black garlic
- kilograms
- garlic
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015218 chewing gum Nutrition 0.000 title claims abstract description 47
- 229940112822 chewing gum Drugs 0.000 title claims abstract description 47
- 241000383638 Allium nigrum Species 0.000 title claims abstract description 30
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 40
- 235000010447 xylitol Nutrition 0.000 claims abstract description 23
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 22
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 22
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000015165 citric acid Nutrition 0.000 claims abstract description 18
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims abstract description 17
- 235000010352 sodium erythorbate Nutrition 0.000 claims abstract description 17
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000811 xylitol Substances 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 15
- 229960002675 xylitol Drugs 0.000 claims abstract description 15
- 240000002234 Allium sativum Species 0.000 claims description 20
- 235000004611 garlic Nutrition 0.000 claims description 20
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 18
- 229940083466 soybean lecithin Drugs 0.000 claims description 18
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium erythorbate Chemical compound [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 12
- 150000000992 L-arabinoses Chemical class 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 29
- 239000008280 blood Substances 0.000 abstract description 24
- 210000004369 blood Anatomy 0.000 abstract description 24
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 10
- 235000012000 cholesterol Nutrition 0.000 abstract description 6
- 150000002632 lipids Chemical class 0.000 abstract description 6
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 230000008030 elimination Effects 0.000 abstract description 2
- 238000003379 elimination reaction Methods 0.000 abstract description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 239000004320 sodium erythorbate Substances 0.000 abstract 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 235000010356 sorbitol Nutrition 0.000 abstract 1
- 239000008347 soybean phospholipid Substances 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 17
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 12
- 206010012601 diabetes mellitus Diseases 0.000 description 11
- 235000013305 food Nutrition 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 229930006000 Sucrose Natural products 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 244000068988 Glycine max Species 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 208000030194 mouth disease Diseases 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000010641 Tooth disease Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000001055 chewing effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 125000003599 L-arabinosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)CO1)* 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000000170 anti-cariogenic effect Effects 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037086 body physiology Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000006377 glucose transport Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001460 masseteric effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- -1 triterpene compound Chemical class 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Confectionery (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses black garlic chewing gum. The black garlic chewing gum is mainly made from black garlic, L-arabinose, tea polyphenols, soybean phospholipids, xylitol, sorbitol, sodium erythorbate, citric acid and the like with gum base according to a certain weight ratio. The black garlic chewing gum satisfies people for leisure and fashion consumption and can be chewed to effectively promote elimination of human radicals, enhance human immunity, stabilize blood pressure, lower blood lipid and blood sugar, lower cholesterol and reduce weight, and fine health caring effect is achieved.
Description
Technical field
The invention belongs to food processing field, relate to a kind of black garlic chewing gum.
Background technology
The Along with people's growth in the living standard, chewing gum receives consumer's welcome as a kind of fashional consumption food, chewing gum commonly used; Can play strengthen masseteric muscle power, clean the teeth, the effect of fresh breath, but owing to wherein add sucrose and some sweeteners of high heat, the sugar of chewing gum part can cause growing of oral bacteria too; Cause carious tooth and mouth disease, when people are doted on chewing gum, can access health-care effect; Should be paid attention to; Patent documentation CN1225181C discloses the pentacyclic triterpene compound that utilizes caulis bambusae in taenian to extract and has processed chewing gum, but to trencherman's alleviating fatigue, enhances human body physiology regulating power plays very good effect; But its sweetener is mainly taken Icing Sugar and glucose syrup, and it is unfavorable that this consumes for the crowd who suffers from diabetes, hyperglycaemia, obesity.
The objective of the invention is to provide a kind of and can supply people's Leisure Consumption, can bring health care, sanatory a kind of black garlic chewing gum to people again simultaneously.
Black garlic; Be to process through hot and humid specified conditions fermentation, because uncooked garlic makes original composition that very about-face take place at physics and chemical change that sweat produces by uncooked garlic head or uncooked garlic lobe; Wherein the content of polyphenol and free amino acid and FOS substantially exceeds uncooked garlic; Produced Ai Qiao grace S-pi-allyl-L-cysteine simultaneously, water-soluble polyphenoils is 8.7 times of living garlic, and fat-soluble polyphenoils is 79 times of living garlic; Have enhancing human immune, antiallergy, anti-ageing, anticancer, suppress artery sclerosis, steadily blood pressure, reducing blood lipid, hypoglycemic, reduce effects such as cholesterol, treatment constipation, beauty treatment; Black garlic flavour after the fermentation is sweet, eats and can not produce unpleasant garlic odour implication, more can not cause the excitant injury to coat of the stomach; This is to expanding the application space of garlic, and the development and utilization garlic has played positive effect.
The L-arabinose is the five carbon atoms sugar that from corncob stalk, pericarp hemicellulose, extracts, separates and obtain, the arabinose that is otherwise known as, and its sugariness is the half the of sucrose; L-arabinose itself is difficult to absorbed by alimentary canal; Even long-term eating can not have toxicity to human body to the health deleterious impact yet, the part that is not used in vivo can be discharged metabolism and the absorption that suppresses sucrose from urine; Therefore auxiliary blood sugar reducing function is arranged; The L-arabinose is as a kind of sugar low in calories, can suppress to raise because of taking in the blood sugar that sucrose causes, and prevention and the treatment disease relevant with hyperglycaemia played the effect of assistant hypoglycemic; Can reach the effect that reduces blood sugar through the absorption of the sucrose in the high fat high-carbonhydrate diet of effective inhibition; Can reduce and stable blood glucose value, thereby
Play protection and repairing pancreas, the effect of prevention diabetes.The change effect of skeletal muscle fibre composition of L-arabinose influences the growth of stomach fat tissue through the domination glycolysis to glycosyloxyization, and the change of this muscle fibre ratio has the effect that improves type II diabetes and obesity.It is to suppress sucrase active in the human small intestine that the L-arabinose acts on the most significantly; Thereby regulate the excessive absorption of human body to sucrose, it can also activate in enteron aisle, breed beneficial bacterium simultaneously, improves metabolic function; Can regulate blood sugar, blood fat and minimizing fat accumulation; Make it good, also have combing skeletal muscle, effects such as sterilizing oral in addition in the application prospect of aspects such as fat-reducing, control diabetes; The L-arabinose has solved and has not only kept sweet taste but also green health and healthy contradiction; The L-arabinose has effects such as hypoglycemic is protected kidney, relaxed bowel, toxin-expelling and face nourishing, beauty and skin care, adjusting blood sugar, the fat fat-reducing of dispelling, and is widely used in the specific crowd of " three high surpass " abroad as raw material.In May, 2008, the L-arabinose is " new resource food " by the health ministry approval.
Sorbierite is nonvolatile polyalcohol, as sweetener, takes the back and in blood, can not be converted into the influence that glucose does not receive insulin yet, is suitable for diabetes, hepatopathy patient.Sorbierite can also keep that food is sweet, sour, the balance of bitter taste and intrinsic fragrance and the local flavor of food.
Xylitol, it is sweet to distinguish the flavor of, and sugariness and sucrose are suitable, and human body does not receive the influence of insulin after xylitol is absorbed, and then avoids blood sugar to raise, thus the suitable sweetener of doing the diabetic of xylitol, the unlikely carious tooth of xylitol and anticariogenic effect is arranged.
Soybean lecithin by the byproduct behind the soybean extract oil, extracts, separates and get through organic solvent; Highly purified soybean lecithin mainly is made up of lecithin, cephalin and lipositol, is to constitute biomembranous main component, and be the indispensable base substance of human body; Human body is through the picked-up to phosphatide; Can improve the power of regeneration of metabolic capability, self-healing ability and the antibody tissue of human body, the biologos of enhances human body, delaying human body caducity; Soybean lecithin plays softening blood vessel, improves serum lipids; The effect of removing peroxide makes cholesterol and fat content reduction in the blood; Thereby reduce the blood stickiness; Can effectively reduce too high blood fat and cholesterol through taking soybean lecithin, thereby prevent and treat diseases such as coronary heart disease, hypertension, miocardial infarction, cerebral thrombus, cerebral hemorrhage, artery sclerosis; Soybean lecithin at the repairing damage brain cell, get through between brain and the blood circulation in the obstacle, can keep the normal function of cranial nerve cell, and strengthen the cerebral nervous system function, and then reach the effect of prevention senile dementia; The science proof is mended food soybean lecithin ability enhance hepatocyte metabolism, promotes fat acid decomposition, protection liver, the generation of illnesss such as prevention fatty liver; Soybean lecithin can strengthen pancreatic functions, repairs the pancreas cell, makes the sufficient insulin of its secretion, reduces blood sugar, effectively with the glucose transport in the blood in cell, thereby alleviate the diabetes state of an illness.
Black garlic and L-arabinose, Tea Polyphenols, soybean lecithin, xylitol, sorbierite and chewing gum base are prepared into chewing gum; Not only can satisfy the fashional consumption of people's leisure; More can reach the elimination of promotion human free radical through chewing delicious chewing gum effectively; Enhancing human immune, steadily blood pressure, reducing blood lipid, hypoglycemic, the effect that reduces cholesterol and fat-reducing can play good health-care effect to promoting health.
Summary of the invention
Main purpose of the present invention provides a kind of black garlic chewing gum; Effects such as this chewing gum has good resistance oxidation, Green Tea Extract, anticancer, antiallergy, anti-ageing, steady blood pressure, regulate blood sugar and blood fat, anti arteriosclerosis, fat-reducing, control atonic constipation; But effective cleaning sterilization oral cavity prevents and treats carious tooth and mouth disease.
The present invention realizes through following technical scheme:
A kind of black garlic chewing gum, it is to be processed by following materials of weight proportions:
Black garlic 6-20 part L-arabinose 0.5-8 part Tea Polyphenols 0.5-3 part
Soybean lecithin 1-8 part xylitol 5-25 part sorbierite 10-30 part
Sodium isoascorbate 0.5-5 part citric acid 0.5-4 part chewing gum base 35-60 part
The preferred weight proportioning of the various raw materials of a kind of black garlic chewing gum of preparation the present invention is:
Black garlic 8-15 part L-arabinose 1-7 part Tea Polyphenols 1-2 part
Soybean lecithin 2-7 part xylitol 10-20 part sorbierite 12-20 part
Sodium isoascorbate 1-4 part citric acid 1-3 part chewing gum base 40-50 part
The optimum weight ratio of each raw material of a kind of black garlic chewing gum of preparation the present invention is:
1.5 parts of black 5 parts of Tea Polyphenols of 10 portions of L-arabinoses of garlic
15 parts of 15 parts of sorbierites of 5 parts of xylitols of soybean lecithin
44 parts of 2 parts of chewing gum bases of 2.5 parts of citric acids of sodium isoascorbate
The preparation method of a kind of black garlic chewing gum of the present invention is similar with the preparation method of chewing gum in the prior art.Its preparation process is:
(1) the black garlic that takes by weighing the formula material amount is pulverized with airslide disintegrating mill through freeze drying, and is subsequent use behind 300 mesh sieves excessively;
(2) the L-arabinose, Tea Polyphenols, soybean lecithin, xylitol, sorbierite, sodium isoascorbate, citric acid that takes by weighing the formula material amount mixes and carries out disinfection and handle, and pulverizes behind 150 mesh sieves subsequent use then;
(3) take by weighing the chewing gum base of formula ratio, and carry out the softening processing of drying glue;
(4) step (1) and each raw material of step (2) mixed drop in the handled chewing gum base of step (3), stir, compressing tablet, can pack after aging finished product.
Each raw material of the present invention all can be buied in market, and wherein, black garlic has been common commercially available prod at present, like the black garlic that the green food picked from the fields article Co., Ltd in Xuzhou produces, the black garlic that has the whole big head of garlic and garlic bulblet to process respectively.
It is the crystalloid powder-product that the present invention selects sorbierite for use.
Sodium isoascorbate is the optical isomer of ascorbic acid (vitamin C); Its oxidation resistance is stronger; In product of the present invention, use jointly with citric acid, its oxidation resistance is strengthened, and produces better effect; Wherein citric acid removes the effect of in this formula for a product, playing acid and flavouring, and more outstanding effect is to play the effect of antioxidant synergist.
Tea Polyphenols, pharmacological research confirms: (1) has antioxygenic property and Green Tea Extract ability, and is anti-ageing, stops lipid peroxidation; (2) hemangiectasis, improve microcirculation, reduce platelet aggregation property, improve hemorheology status, strengthen the heart, brain supply of blood flow; (3) reducing blood lipid, hypoglycemic, prevent and treat hypertension and antiatherosclerosis; (4) antitumor, anti-sudden change, anti-curing cancers; (5) anti-inflammation; (6) health-care effect; (7) hepatoprotective effect; (8) antiallergic action; (9) immunoregulation effect (Jia Gongfu chief editor, clinical medicine is newly used coupling complete works of (the 2nd edition), People's Health Publisher in December, 2006,1107 pages).Tea Polyphenols remove have anti-oxidant, anti-sudden change, biological functions such as anticancer change, anti-ageing, removing free radical, hypotensive and cholesterol; In functional food, using as antioxidant, anticorrisive agent has anti-oxidant, anti-corrosive fresh-keeping, protects look, protects vitamin, removes peculiar smell, improves the function of flavour of food products; Be used with sodium isoascorbate, soybean lecithin and citric acid etc.; Have obvious synergistic effect, in addition, Tea Polyphenols also has good bacteriostasis; Application in product of the present invention is with playing good health care synergy and to the guaranteeing role of product quality.
The primary raw material that chewing gum of the present invention is selected can be so that each material effect produces well collaborative and synergistic effect with combination; Regulate physiological function effectively; At anti-oxidant removing human free radical; Enhancing human immune, anti-ageing, anticancer change, suppress artery sclerosis, steadily blood pressure, reducing blood lipid, hypoglycemic, reduce courage alcohol, anti-ly treat constipation, lose weight and the oral cavity of sterilize, prevent and treat mouth disease, will be in the process of chewing the food chewing gum the useful health-care effect of acquisition.
Beneficial effect of the present invention also is; The content of people's interior free yl improves constantly owing to environmental factor; Removing free radical is one of factor of disease preventing and treating generation, and the black garlic in the combination raw materials among the present invention, Tea Polyphenols are the active principles of generally acknowledging at present, and the L-arabinose in the prescription is generally acknowledge now healthy sugared; Can effectively prevent and alleviate the misery of diabetic population, also have good effect of weight reducing; Soybean lecithin is described as the patron saint of liver, and the while is again delaying human body caducity, angiocardiopathy preventing, alleviates the health nutrient of the diabetes state of an illness, and product of the present invention also is; Sweetener xylitol in its composition of raw materials not only has abundant sugariness, and in mouth, can produce happy refrigerant sense, and metabolism and insulin are irrelevant in vivo; The diabetic uses these article does not increase blood glucose value, is beneficial to the diabetic and chews food, the unlikely dental caries of xylitol; And the anti-caries effect is arranged, and xylitol can also produce chelation with metal ion, can increase the effect of antioxidant; The stability of product of the present invention can be protected, sorbierite, it is sweet and refrigerant to distinguish the flavor of; Sugariness is about 60% of sucrose, and human body is not converted into glucose after taking in sorbierite in blood, and its metabolic process is not controlled by insulin; And safe, suitable diabetes, hepatopathy, cholecystitis edible for patients, these auxiliary materials and black garlic, L-arabinose, Tea Polyphenols are used for the major function raw material; More become rationally, can give full play to the health-care efficacy of chewing gum.When black garlic chewing gum provides a kind of fashionable recreation food to people, the effect of the health care good for health of getting back, the suitable more consumer group selects for use, and market prospects are wide.
The specific embodiment
Below further the preparation method of a kind of black garlic chewing gum of the present invention is done with explanation, but it is not a limitation of the present invention through embodiment.
Embodiment 1
0.5 kilogram of black 3 kilograms of Tea Polyphenols of 20 kilograms of L-arabinoses of garlic
10 kilograms of 20 kilograms of sorbierites of 7 kilograms of xylitols of soybean phosphine fat
36 kilograms of 2.5 kilograms of chewing gum bases of 1 kilogram of citric acid of sodium isoascorbate
(1) the black garlic that takes by weighing the formula material amount is pulverized with airslide disintegrating mill through freeze drying, and it is subsequent use to cross 300 mesh sieves;
(2) the L-arabinose, Tea Polyphenols, soybean lecithin, xylitol, sorbierite, sodium isoascorbate, citric acid that takes by weighing the formula material amount mixes and carries out disinfection and handle, and pulverizes behind 150 mesh sieves subsequent use then;
(3) take by weighing the chewing gum base of formula ratio, and carry out the softening processing of drying glue;
(4) step (1) and each raw material of step (2) are mixed drop in the handled chewing gum base of step (3), stir, compressing tablet, can pack after aging, must deceive garlic chewing gum finished product.
Embodiment 2
1 kilogram of black 1 kilogram of Tea Polyphenols of 15 kilograms of L-arabinoses of garlic
12 kilograms of 20 kilograms of sorbierites of 2 kilograms of xylitols of soybean phosphine fat
44 kilograms of 1 kilogram of chewing gum bases of 4 kilograms of citric acids of sodium isoascorbate
Preparation method's step of present embodiment is identical with the step described in the embodiment 1.
Embodiment 3
0.25 kilogram of black 7 kilograms of Tea Polyphenols of 10 kilograms of L-arabinoses of garlic
13 kilograms of 10 kilograms of sorbierites of 6 kilograms of xylitols of soybean phosphine fat
50 kilograms of 2.5 kilograms of chewing gum bases of 1.25 kilograms of citric acids of sodium isoascorbate
Preparation method's step of present embodiment is identical with the step described in the embodiment 1.
Embodiment 4
0.5 kilogram of black 5 kilograms of Tea Polyphenols of 10 kilograms of L-arabinoses of garlic
15 kilograms of 15 kilograms of sorbierites of 5 kilograms of xylitols of soybean phosphine fat
45 kilograms of 2 kilograms of chewing gum bases of 2.5 kilograms of citric acids of sodium isoascorbate
Preparation method's step of present embodiment is identical with the step described in the embodiment 1.
Embodiment 5
1 kilogram of black 3 kilograms of Tea Polyphenols of 8 kilograms of L-arabinoses of garlic
20 kilograms of 10 kilograms of sorbierites of 6 kilograms of xylitols of soybean phosphine fat
47.5 kilograms of 1.5 kilograms of chewing gum bases of 3 kilograms of citric acids of sodium isoascorbate
Preparation method's step of present embodiment is identical with the step described in the embodiment 1.
Embodiment 6
0.25 kilogram of black 2 kilograms of Tea Polyphenols of 12 kilograms of L-arabinoses of garlic
12 kilograms of 10 kilograms of sorbierites of 3 kilograms of xylitols of soybean phosphine fat
58 kilograms of 1.5 kilograms of chewing gum bases of 1.25 kilograms of citric acids of sodium isoascorbate
Preparation method's step of present embodiment is identical with the step described in the embodiment 1.
Claims (3)
1. black garlic chewing gum is characterized in that it is to be processed by following materials of weight proportions:
Black garlic 6-20 part L-arabinose 0.5-8 part Tea Polyphenols 0.5-3 part
Soybean lecithin 1-8 part xylitol 5-25 part sorbierite 10-30 part
Sodium isoascorbate 0.5-5 part citric acid 0.5-4 part chewing gum base 35-60 part.
2. chewing gum according to claim 1 is characterized in that wherein the weight proportion of each raw material is:
Black garlic 8-15 part L-arabinose 1-7 part Tea Polyphenols 1-2 part
Soybean lecithin 2-7 part xylitol 10-20 part sorbierite 12-20 part
Sodium isoascorbate 1-4 part citric acid 1-3 part chewing gum base 40-50 part.
3. chewing gum according to claim 1 is characterized in that wherein the weight proportion of each raw material is:
1.5 parts of black 5 parts of Tea Polyphenols of 10 portions of L-arabinoses of garlic
15 parts of 15 parts of sorbierites of 5 parts of xylitols of soybean lecithin
44 parts of 2 parts of chewing gum bases of 2.5 parts of citric acids of sodium isoascorbate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210268722.6A CN102763759B (en) | 2012-08-01 | 2012-08-01 | Black garlic chewing gum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210268722.6A CN102763759B (en) | 2012-08-01 | 2012-08-01 | Black garlic chewing gum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102763759A true CN102763759A (en) | 2012-11-07 |
| CN102763759B CN102763759B (en) | 2014-05-28 |
Family
ID=47091523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210268722.6A Expired - Fee Related CN102763759B (en) | 2012-08-01 | 2012-08-01 | Black garlic chewing gum |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102763759B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103960730A (en) * | 2014-05-22 | 2014-08-06 | 汤敏 | Rhodiola rosea beverage and preparation method thereof |
| CN105166306A (en) * | 2015-08-27 | 2015-12-23 | 济南舜祥医药科技有限公司 | Seaweed chewing gum and preparation method thereof |
| CN106173172A (en) * | 2016-07-06 | 2016-12-07 | 安徽米乐食品有限公司 | A kind of reducing blood pressure and blood fat health-care chewing gum and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101485375A (en) * | 2009-02-20 | 2009-07-22 | 南京工业大学 | Dark Garlic Chocolate and How to Make It |
| CN102488058A (en) * | 2011-12-02 | 2012-06-13 | 徐州工程学院 | Black garlic preserved hawthorn roll and making method thereof |
-
2012
- 2012-08-01 CN CN201210268722.6A patent/CN102763759B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101485375A (en) * | 2009-02-20 | 2009-07-22 | 南京工业大学 | Dark Garlic Chocolate and How to Make It |
| CN102488058A (en) * | 2011-12-02 | 2012-06-13 | 徐州工程学院 | Black garlic preserved hawthorn roll and making method thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103960730A (en) * | 2014-05-22 | 2014-08-06 | 汤敏 | Rhodiola rosea beverage and preparation method thereof |
| CN105166306A (en) * | 2015-08-27 | 2015-12-23 | 济南舜祥医药科技有限公司 | Seaweed chewing gum and preparation method thereof |
| CN106173172A (en) * | 2016-07-06 | 2016-12-07 | 安徽米乐食品有限公司 | A kind of reducing blood pressure and blood fat health-care chewing gum and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102763759B (en) | 2014-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102076459B1 (en) | Composition containing enzyme treatmented Tenebrio molitor for muscle mass enhancement and restorative rejuvenation of recovering patients or elderly patients | |
| CN102224891B (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| CN101278994A (en) | Prinsepia utilis Royle oral nursing soft capsules | |
| KR101294762B1 (en) | Functional soap and manufacturing method of it | |
| CN105942498A (en) | Functional nutritional food compounds with diabetes-treating effects and preparation methods thereof | |
| CN109349489A (en) | A kind of solid beverage and preparation method thereof with function of delaying senility | |
| KR101018065B1 (en) | Health drink manufacturing method using jujube and health drink produced by | |
| KR20210142545A (en) | Manufacturing method of homemade snack of fishery products keeping its original form for companion animal and homemade snack of fishery products keeping its original form for companion animal manufactured using the method | |
| CN107455625A (en) | A kind of nutrient for plants beverage and its preparation technology with antifatigue weight losing function | |
| JP6463504B2 (en) | Health supplements for hair growth promotion, hair loss relief and improvement, blood sugar control, gastrointestinal symptom relief and improvement | |
| CN109497227A (en) | A kind of brown sugar Qi jujube Health care ginger tea | |
| CN101766274A (en) | Antioxidant functional food composition containing bamboo-leaves flavones | |
| CN106070626A (en) | Kumiss fruit drink and preparation method thereof | |
| CN103168815A (en) | Gingko tartary buckwheat cookie and manufacturing method thereof | |
| CN102763759B (en) | Black garlic chewing gum | |
| KR20130063074A (en) | Blood glucose and blood pressure decrease action composition | |
| KR20110119305A (en) | Functional drink composition containing taurine, vitamins, royal jelly, red ginseng, goji berry, glutamate (thalmic rice, mibea) and apple essence as main ingredients | |
| KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
| KR101186508B1 (en) | Manufacturing method of healthy food using germinated grain | |
| CN104958233B (en) | A kind of cat toothpaste and preparation method thereof | |
| CN102823706A (en) | Production method of jelly using black garlic as base | |
| KR20130029284A (en) | Composition of healthy foods for treatment of dementia | |
| JP4949272B2 (en) | Mixed herbal extract of eringi, goka and sesame root, and composition for preventing and treating periodontal disease comprising the same as an active ingredient | |
| CN106259966A (en) | A kind of honeydew local flavor Semen Armeniacae Amarum bean milk and preparation method thereof | |
| CN106174286A (en) | Senior gold Chinese-wolfberry nutritive fruit jam |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: ZHANG ZHINIAN Effective date: 20140418 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhinian Inventor after: Zhang Kuichang Inventor before: Zhang Kuichang Inventor before: Zhang Zhinian |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG KUICHANG ZHANG ZHINIAN TO: ZHANG ZHINIAN ZHANG KUICHANG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140418 Address after: 221300 Jiangsu city of Xuzhou province Pizhou City, Su Yang Town High Road No. 1 Applicant after: Xuzhou Lvzhiye Biological Food Co., Ltd. Address before: 221300 Jiangsu city of Xuzhou province Pizhou city road construction Tongsheng International Plaza 8 North Building Room 1-201 Applicant before: Xuzhou Lvzhiye Biological Food Co., Ltd. Applicant before: Zhang Zhinian |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140528 Termination date: 20200801 |